Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease - Wikidata - awgldk - TriplyDB

Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease

Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease

http://www.wikidata.org/entity/Q33494148

about

Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention Redox modification of cell signaling in the cardiovascular system Hsp70.1 and related lysosomal factors for necrotic neuronal death Proteomics of protein post-translational modifications implicated in neurodegeneration Mass spectrometry-based methods for identifying oxidized proteins in disease: advances and challenges Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease.Protein carbonylation.Nitrosative stress induces peroxiredoxin 1 ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivo.Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders.Heat shock protein 70.1 (Hsp70.1) affects neuronal cell fate by regulating lysosomal acid sphingomyelinase.Chemical probes for analysis of carbonylated proteins: a review.Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders Determination of protein carbonyls in plasma, cell extracts, tissue homogenates, isolated proteins: Focus on sample preparation and derivatization conditions.Heat shock response and insulin-associated neurodegeneration.Cardiovascular redox and ox stress proteomics.A multifunctional ELISA to measure oxidised proteins: oxPin1 in Alzheimer's brain as an example Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer's Disease Mice.Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.Nitric oxide signaling in brain function, dysfunction, and dementia.Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease.The neuropathological profile of mild cognitive impairment (MCI): a systematic review.Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders.Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies.Mass spectrometry and redox proteomics: applications in disease.Similarities in lindane induced alterations in protein expression profiling in different brain regions with neurodegenerative diseases.Natural reduced water suppressed anxiety and protected the heightened oxidative stress in rats.Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese.Identification of a nuclear carbonic anhydrase in Caenorhabditis elegans.Discovery of Age-Related Protein Folding Stability Differences in the Mouse Brain Proteome.Redox proteomics: from protein modifications to cellular dysfunction and disease.Why are hippocampal CA1 neurons vulnerable but motor cortex neurons resistant to transient ischemia?Solid-phase synthesis of peptides containing aminoadipic semialdehyde moiety and their cyclisations.

P2860

Q26771736-B87BCA32-D838-4F50-B71D-FBDD5E209646 Q26827320-4A08E62A-4A66-41D7-A45D-056EB2A08AC5 Q26865358-0C72F4AB-82B9-4027-94B0-63327AAD0463 Q27000640-F7CC2898-A501-4325-9342-91807C745A77 Q27012978-AF23E679-65B5-46ED-8A16-4FC8D3801724 Q28088631-BFDBC65F-8035-4BDD-B110-B3C2868079A7 Q28382957-6907123E-1F6C-4719-80EA-078C4855BAD2 Q30393354-DB51E778-FFD5-4BD3-8A2F-AE5E46029454 Q30446460-B6A33578-C088-457E-AB6F-A2562901E349 Q33552777-04A3E1E8-DD9F-4858-8C37-D8A97BAE763C Q33649892-C6CB0A13-C152-4AE6-9551-96732A1926F4 Q33722929-53348025-A091-4C47-94ED-F72697BBE0E3 Q33857238-38B71B9C-6276-4675-A7E1-5DCB2C813FD4 Q33912803-6E9DF8B3-0087-47B2-BC91-E641CDC501E3 Q34094516-941BED06-0F72-4ECD-AD1C-4735A1F25E14 Q34185195-F51A75FC-A8A1-4835-BD2E-E113763D951D Q34283362-9B09A99B-5625-42F7-B93C-046B7C216360 Q34372674-93CF8E82-33B4-4346-AC9D-D5CB02DA8633 Q35087574-E6B165FC-855E-44B7-A14B-57802EE61551 Q35682608-477BED9A-C043-4A53-8E8F-EF947BE2C91C Q35870561-6B5C00D9-4128-4771-9FA1-27D5BD7E561F Q36252927-C669DA07-A85E-4EEC-83C0-4EBA6D0D6705 Q36323907-4F7EEB50-5F41-41FA-ACEA-91D0E615D621 Q36846943-6E95850F-4385-49F6-B8DA-E9232148CD4B Q37130046-E2B79044-D04A-40A3-A23F-99510B825F84 Q37603401-10DFD841-EBB0-4AB9-82FA-ACDB665EE77A Q37785420-85EB7C71-F4B8-4985-9F57-31C355876118 Q37956168-4B6F9538-3627-48F6-ACA5-FC2720BF57A3 Q37964897-EE9AD930-3D4F-4A8A-994C-F2E76B8229DC Q38019745-F951B7AD-4143-4325-AA7E-F5F8587B9B1D Q38119881-87B27048-976E-4F1F-AFFB-ABE19896FEF9 Q38220377-64C71638-835E-4155-BA12-9419377D185E Q40562480-669988C3-DB9B-4952-B3F5-93747A92EF5D Q41080993-A7C9D7DA-F82E-4447-855A-4F30B46511F9 Q42070989-FF6E5C50-1943-407C-8DD7-021454EE82B5 Q42160367-0D9D4719-00EA-48CE-8209-2F8D4B891C83 Q44796586-FCDB616B-6DB9-4EA5-A132-25812204EEAD Q46966345-BB9D44D3-ADAD-4CE4-B605-3B6CD560C34C Q48826937-2A27B31A-C229-4019-B948-0C7A03BF7EF9 Q55645664-9452E14B-4E4A-4441-9B3C-84369B5C8500

P2860

Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease

http://www.wikidata.org/entity/Q33494148

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Redox proteomic analysis of ca ...... and early Alzheimer's disease

@ast

Redox proteomic analysis of ca ...... and early Alzheimer's disease

@en

type

label

Redox proteomic analysis of ca ...... and early Alzheimer's disease

@ast

Redox proteomic analysis of ca ...... and early Alzheimer's disease

@en

prefLabel

Redox proteomic analysis of ca ...... and early Alzheimer's disease

@ast

Redox proteomic analysis of ca ...... and early Alzheimer's disease

@en

P1433

Q33494148-201C4AEA-C2CC-4F98-B26E-1C21BDBD19BE

P1476

Q33494148-6B6DC9DE-1937-4801-86A5-C15002FB91E5

P2093

Q33494148-02A49665-BD72-480C-9F6B-FC42067CA9FD

Q33494148-A471CF9B-5FB4-467B-8EE7-805DE1F1A41D

Q33494148-F3FAF86C-3FE5-4A72-B726-AE1490DC9B05

Q33494148-F464274C-1F04-4FA9-86C5-5A7209A15AF7

P2860

Q33494148-01CE8E6C-B4B9-4DF3-A34D-73B68C05E4DF

Q33494148-0256F91C-B2C1-4DBB-9F85-1D0E11786FCD

Q33494148-02C834FD-F2E9-4438-87CB-2C4A033DF90D

Q33494148-07FD8D67-59B3-431F-966C-BEBD676F0224

Q33494148-0F146E69-69F2-4A44-B527-F49A163BB556

Q33494148-11F83804-4315-46AE-A990-A7150C58A0A2

Q33494148-221254EF-F846-4619-B49B-798A9FE8AF5A

Q33494148-23628C1D-6D73-4E97-B40B-EC07FA2ACF43

Q33494148-238D5CC9-2D33-4D68-80FB-9425E9F3AA90

Q33494148-30A274DD-46E5-4E33-9B58-5765B9E07904

P304

Q33494148-E5B74378-D73C-4552-81A0-C36A11D2B5CF

P31

Q33494148-248A3ACD-AE10-4F9A-A176-7C956AC941DA

P356

Q33494148-B950BB18-9FA1-4C1C-94AC-43CF95BB1220

P433

Q33494148-0359D451-C0F1-4133-A67E-5E693EB51954

P478

Q33494148-F989B7F9-5800-4501-A0AD-5437B4AC7547

P50

Q33494148-15FD0F93-6A5B-40A8-9A17-8FBA6F3A6235

Q33494148-6581AE5D-2078-48AB-A9BB-DAD981321471

Q33494148-8F258232-DC3E-4E6E-B731-D1B9EA877F09

P577

Q33494148-0182308E-D70D-4821-8F6A-C5ED0C34C8F2

P5875

Q33494148-CCCCB6E9-6E10-4511-9083-97F5ABE6D4F2

P698

Q33494148-8C06E9A7-FA83-4734-80DC-0FD24190E0B9

P921

Q33494148-FF66F408-5320-4900-B9D2-64DD9B73B435

P932

Q33494148-8BB6CC36-EA11-4F1B-AFED-231CD8FB12D6

P356

P1433

Antioxidants & Redox Signaling

P1476

Redox proteomic analysis of ca ...... and early Alzheimer's disease

@en

P2093

Marzia Perluigi

http://www.w3.org/2001/XMLSchema#string

Rukhsana Sultana

http://www.w3.org/2001/XMLSchema#string

Shelley F Newman

http://www.w3.org/2001/XMLSchema#string

William M Pierce

http://www.w3.org/2001/XMLSchema#string

P2860

Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease

Alzheimer's disease: genes, proteins, and therapy

Oxidative stress and neurodegeneration: where are we now?

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease.

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease.

Carbonic anhydrase gating of attention: memory therapy and enhancement.

Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

The role of mitogen-activated protein kinase pathways in Alzheimer's disease.

P304

327-336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/ARS.2009.2810

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Raffaella Coccia

D Allan Butterfield

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26747155

http://www.w3.org/2001/XMLSchema#string

P698

19686046

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2821142

http://www.w3.org/2001/XMLSchema#string